Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Macular EdemaRetinal Vein Occlusion
Interventions
DRUG

4 mg CLS-TA

40 mg/mL CLS-TA, Clearside's formulation of TA (CLS-TA, triamcinolone acetonide injectable suspension)

DRUG

Sham

suprachoroidal sham procedure

DRUG

IVT aflibercept

2 mg intravitreal injection of aflibercept

Trial Locations (14)

21287

Baltimore

27157

Winston-Salem

30322

Atlanta

33426

Boynton Beach

57701

Rapid City

63128

St Louis

77030

Houston

77384

The Woodlands

78251

San Antonio

78503

McAllen

79606

Abilene

85014

Phoenix

90211

Beverly Hills

92037

San Diego

Sponsors
All Listed Sponsors
lead

Clearside Biomedical, Inc.

INDUSTRY